Cannabis operator Canopy to be booted off S&P/TSX Composite Index
Canadian-listed shares of cannabis operator Canopy Growth Corp. will be removed from the S&P/TSX Composite Index, a market benchmark equivalent to the S&P 500 in the United States.
Canadian-listed shares of cannabis operator Canopy Growth Corp. will be removed from the S&P/TSX Composite Index, a market benchmark equivalent to the S&P 500 in the United States.
Toronto-based Cronos Group is pulling out of the U.S. hemp-derived CBD market “to improve its cash flow in the near term.”
Canadian cannabinoid product company Avicanna has revealed how much it is paying to buy a medical cannabis business from major Canadian pharmacy chain Shoppers Drug Mart: 2.6 million Canadian dollars ($1.9 million).
Canadian marijuana retail chain Fire & Flower Holdings says it is “reviewing strategic options including financing options,” as the company requires more funding to continue doing business.
Canadian producer Organigram Holdings is investing as much as $8 million in Portland, Oregon-based cannabis genetics and seeds company Phylos Bioscience.
Canadian cannabis producer Aleafia Health has launched a strategic review process to determine the company’s options as it amends the terms of a loan from lender NE SPC II.
At a time when the accuracy of cannabis label claims is already under scrutiny, recalls for erroneous labels may matter more than ever.
New Jersey’s cannabis regulator says the state’s first two recreational-only marijuana retail stores are now open after being granted licenses.
The government of Costa Rica issued the first business license to cultivate and process marijuana for medical purposes to Azul Wellness S.A.
New Mexico’s regulated medical marijuana program will permit insomnia as a qualifying condition effective June 1, a move that could potentially expand the state’s MMJ market.
Cannabis industry financial services company Safe Harbor Financial announced a marijuana business banking partnership with Five Star Bank.
Cumulative sales of legal, regulated medical and adult-use marijuana in Missouri surpassed $1 billion as of early May.